Alpine Global Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Alpine Global Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-40,162	Closed	-$133K	–	246
2016 Q2	$133K	Buy	+40,162	New	+$152K	0.06%	110

Other funds holding ARLZ

PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Tiger Legatus Capital Management New York $62.4M AUM 24.33% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

Alpine Global Management's ARLZ Position: Q3 2016 in Review

Alpine Global Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2016, closing a stake of 40,162 shares — an estimated $133K sold.

Alpine Global Management first reported a position in ARLZ in Q2 2016 and held it in 1 quarter. The position peaked at $133K in Q2 2016. 83 funds tracked by Wall St. Rank hold ARLZ as of Q3 2016.

Alpine Global Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
Alpine Global Management sold 40,162 Aralez Pharmaceuticals Inc. shares in Q3 2016, an estimated $133K.
Alpine Global Management first reported a position in Aralez Pharmaceuticals Inc. in Q2 2016 and held it in 1 quarter.
Alpine Global Management's Aralez Pharmaceuticals Inc. position peaked at $133K in Q2 2016.
83 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2016.

Based on Alpine Global Management's 13F filing for Q3 2016, filed 15 Nov 2016.